Safety and tolerability of adjunctive eslicarbazepine acetate in adolescents with focal-onset seizures: Data from three double-blind, placebo-controlled randomized clinical studies

被引:0
|
作者
Garcia-Penas, Juan-Jose [1 ]
Ikedo, Fabio [2 ]
Fonseca, Miguel [2 ]
Fernandez, Guillermo Castilla [2 ]
Pereira, Ana [2 ]
Moreira, Joana [2 ]
Gama, Helena [2 ]
机构
[1] Nino Jesus Pediat Univ Hosp, Epilepsy Unit, Neuropediat Sect, Madrid, Spain
[2] BIAL Portela & Ca SAS Mamede Coronado, Div Res & Dev, Porto, Portugal
关键词
D O I
10.1016/j.jns.2021.119157
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
119157
引用
收藏
页码:159 / 160
页数:2
相关论文
共 50 条
  • [1] Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies
    Elger, Christian
    Koepp, Mathias
    Trinka, Eugen
    Villanueva, Vicente
    Chaves, Joao
    Ben-Menachen, Elinor
    Kowacs, Pedro A.
    Gil-Nagel, Antonio
    Moreira, Joana
    Gama, Helena
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (12) : 961 - 972
  • [2] Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial
    Kirkham, Fenella
    Auvin, Stephane
    Moreira, Joana
    Gama, Helena
    Falcao, Amilcar C.
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    EPILEPSY & BEHAVIOR, 2020, 105
  • [3] TOLERABILITY OF CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS IN THREE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Sperling, M. R.
    Faught, E.
    Schmitt, J.
    Wiegand, F.
    Novak, G.
    EPILEPSIA, 2009, 50 : 66 - 66
  • [4] Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial
    Inoue, Yushi
    Tiamkao, Somsak
    Zhou, Dong
    Cabral-Lim, Leonor
    Lim, Kheng Seang
    Lim, Shih-Hui
    Tsai, Jing-Jane
    Moseley, Brian
    Wang, Lin
    Sun, Weiwei
    Hayakawa, Yoshinobu
    Sasamoto, Hiroshi
    Sano, Tomonobu
    Mcclung, Carrie
    Bass, Almasa
    EPILEPSIA OPEN, 2024, 9 (03) : 1007 - 1020
  • [5] Efficacy and Tolerability of Adjunctive Lacosamide in Children and Adolescents with Uncontrolled Focal Seizures: A Randomized, Double-blind, Placebo-controlled
    Farkas, V
    Steinborn, B.
    Flamini, J.
    Dilley, D.
    Bozorg, A.
    Daniels, T.
    Scheffer, I
    ANNALS OF NEUROLOGY, 2017, 82 : S287 - S290
  • [6] MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF SUSTAINED-RELEASE VINPOCETINE AS ADJUNCTIVE TREATMENT OF FOCAL-ONSET SEIZURES
    Garza-Morales, S. J.
    Pizarro-Castellanos, M.
    Sitges-Berrondo, M.
    Briceno-Gonzalez, E.
    Ceja-Moreno, H.
    Rodriguez-Leyva, I.
    Alonso-Rivera, C.
    Gongora-Rivera, F.
    Ruiz-Sandoval, L.
    EPILEPSIA, 2015, 56 : 12 - 12
  • [7] Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials
    Biton, Victor
    Gil-Nagel, Antonio
    Isojarvi, Jouko
    Doty, Pamela
    Hebert, David
    Fountain, Nathan B.
    EPILEPSY & BEHAVIOR, 2015, 52 : 119 - 127
  • [9] Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials
    Moseley, Brian
    Bourikas, Dimitrios
    Dimova, Svetlana
    Elmoufti, Sami
    Borghs, Simon
    ADVANCES IN THERAPY, 2024, 41 (04) : 1746 - 1758
  • [10] Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials
    Brian Moseley
    Dimitrios Bourikas
    Svetlana Dimova
    Sami Elmoufti
    Simon Borghs
    Advances in Therapy, 2024, 41 : 1746 - 1758